Document is current
Any future updates will be listed below
-
Authors
Illini, Oliver https://orcid.org/0000-0002-7322-7092
- License Information
-
More Information
Article History
Received: 14 September 2025
Accepted: 3 November 2025
First Online: 27 November 2025
Conflict of interest
: O. Illini has received speaker fees and/or honoraria for advisory board participation from Boehringer Ingelheim, Eli Lilly, Johnson & Johnson, Menarini, Merck Sharp & Dohme, Pfizer, and Roche. Research grants to the institute were received from Amgen, AstraZeneca, and Takeda outside the submitted work.
